1 hour ago
2 hours ago
Noureddin recaps recent progress in MASH therapeutic development and looks ahead to what 2026 and beyond may offer.
4 hours ago
This interview at the 2026 Maui Derm Hawaii meeting features a discussion of new and emerging therapies in psoriasis, including icotrokinra.
7 hours ago
Reau and Brown discuss new data on MASH/MASLD, including awareness, referral patterns, discussions around alcohol, and emerging pharmacotherapies.
7 hours ago
The new approval allows for repeat administration of iDose TR, modifying the existing single-administration label.